跳至主要内容
临床试验/NCT00497471
NCT00497471终止不适用

The Prevention of Anaemia and Malaria in Infants in an Area of Intense and Perennial Malaria Transmission

Hospital Clinic of Barcelona1 个研究点 分布在 1 个国家目标入组 832 人开始时间: 1995年2月最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
终止
入组人数
832
试验地点
1
主要终点
Severe Anemia (PCV < 25%)

研究概览

简要总结

The purpose of this trial is to evaluate the efficacy of weekly iron supplementation and the efficacy of malaria chemoprophylaxis from 2 to 12 months of age in infants living in an area of intense and perennial malaria transmission

详细描述

411 Tanzanian infants were randomly assigned to receive weekly malaria prophylaxis with Deltaprim™ (3.125 mg pyrimethamine plus 25 mg dapsone) or placebo from ages 2-12 months. Children were followed-up until age 4 years. Uncomplicated febrile malaria, severe malaria and anaemia morbidity were assessed through hospital-based passive surveillance.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Prevention
盲法
Double

入排标准

年龄范围
1 Day 至 1 Day(Child)
性别
All
接受健康志愿者

入选标准

  • Born in San Francis Designated District Hospital of Ifakara

排除标准

  • Obvious severe congenital malformation such as: spina bifida, hydrocephalus or anencepahlus
  • Birth weight < 1,5 kg
  • Clinical signs of cerebral asphyxia
  • Clinical signs of neonatal or congenital infection
  • Mother unreliable (deaf, mentally handicapped)

结局指标

主要结局

Severe Anemia (PCV < 25%)

时间窗: During first year of life

Clinical Malaria

时间窗: During first year of life

次要结局

  • Severe Anemia (PCV < 25%)(After first year of life)
  • Outpatient visits
  • Severe malaria
  • Clinical Malaria(After first year of life)
  • Hospital Admissions

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验